139 related articles for article (PubMed ID: 29346733)
1. Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication.
Xing Y; Zuo J; Krogstad P; Jung ME
J Med Chem; 2018 Feb; 61(4):1688-1703. PubMed ID: 29346733
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones.
Chern JH; Lee CC; Chang CS; Lee YC; Tai CL; Lin YT; Shia KS; Lee CY; Shih SR
Bioorg Med Chem Lett; 2004 Oct; 14(20):5051-6. PubMed ID: 15380197
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.
Hu Y; Kitamura N; Musharrafieh R; Wang J
J Med Chem; 2021 Jun; 64(12):8755-8774. PubMed ID: 34085827
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors.
Shia KS; Li WT; Chang CM; Hsu MC; Chern JH; Leong MK; Tseng SN; Lee CC; Lee YC; Chen SJ; Peng KC; Tseng HY; Chang YL; Tai CL; Shih SR
J Med Chem; 2002 Apr; 45(8):1644-55. PubMed ID: 11931618
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives.
Chang CS; Lin YT; Shih SR; Lee CC; Lee YC; Tai CL; Tseng SN; Chern JH
J Med Chem; 2005 May; 48(10):3522-35. PubMed ID: 15887961
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolopyridine antiherpetics: SAR of C2' and C7 amine substituents.
Johns BA; Gudmundsson KS; Turner EM; Allen SH; Samano VA; Ray JA; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Creech KL; Moniri KR
Bioorg Med Chem; 2005 Apr; 13(7):2397-411. PubMed ID: 15755642
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates.
Wang Y; Wang H; Jiang X; Jiang Z; Guo T; Ji X; Li Y; Li Y; Li Z
Molecules; 2019 Mar; 24(5):. PubMed ID: 30862068
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of substituted homoisoflavonoids on enteroviruses.
Tait S; Salvati AL; Desideri N; Fiore L
Antiviral Res; 2006 Dec; 72(3):252-5. PubMed ID: 16934879
[TBL] [Abstract][Full Text] [Related]
11. Replication and Inhibitors of Enteroviruses and Parechoviruses.
van der Linden L; Wolthers KC; van Kuppeveld FJ
Viruses; 2015 Aug; 7(8):4529-62. PubMed ID: 26266417
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[1,5-a]pyridine antiherpetics: effects of the C3 substituent on antiviral activity.
Johns BA; Gudmundsson KS; Allen SH
Bioorg Med Chem Lett; 2007 May; 17(10):2858-62. PubMed ID: 17350256
[TBL] [Abstract][Full Text] [Related]
13. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
14. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel purine-based coxsackievirus inhibitors bearing polycylic substituents at the N-9 position.
Dejmek M; Sála M; Plačková P; Hřebabecký H; Mascarell Borredà L; Neyts J; Dračínský M; Procházková E; Jansa P; Leyssen P; Mertlíková-Kaiserová H; Nencka R
Arch Pharm (Weinheim); 2014 Jul; 347(7):478-85. PubMed ID: 24652670
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones.
Kumar Biswas B; Malpani YR; Ha N; Kwon DH; Soo Shin J; Kim HS; Kim C; Bong Han S; Lee CK; Jung YS
Bioorg Med Chem Lett; 2017 Aug; 27(15):3582-3585. PubMed ID: 28587824
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
19. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.
Makarov VA; Braun H; Richter M; Riabova OB; Kirchmair J; Kazakova ES; Seidel N; Wutzler P; Schmidtke M
ChemMedChem; 2015 Oct; 10(10):1629-34. PubMed ID: 26260222
[TBL] [Abstract][Full Text] [Related]
20. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
